RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to shrink tumors before cancer surgery
Disease control Recruiting nowThis study is testing if a new drug called ivonescimab can help shrink tumors before surgery for head and neck cancer. The drug is designed to help the body's immune system fight the cancer cells. Researchers will give the drug to about 28 patients and then measure how much the t…
Matched conditions: RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Early trial aims to boost cancer treatment power
Disease control Recruiting nowThis early-stage study is testing the safety and best dose of a drug called decitabine when added to standard surgery and radiation for a specific type of head and neck cancer not linked to HPV. The goal is to see if decitabine makes the cancer cells more sensitive to the standar…
Matched conditions: RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New attack on tough head & neck cancers that come back
Disease control Recruiting nowThis early-stage trial is testing whether combining an immunotherapy drug called pembrolizumab with surgery and targeted radiation can better control head and neck cancers that have returned or didn't fully respond to previous treatments. The study aims to find the safest way to …
Matched conditions: RESECTABLE HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC